Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis. [electronic resource]
Producer: 20110217Description: 230-2 p. digitalISSN:- 1468-330X
- Aged
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Autoimmune Diseases -- drug therapy
- Electroencephalography
- Electromyography
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Magnetic Resonance Imaging
- Male
- Methylprednisolone -- therapeutic use
- Myasthenia Gravis -- drug therapy
- Neural Conduction -- physiology
- Neurologic Examination
- Plasma Exchange
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating -- drug therapy
- Rituximab
- Syringomyelia -- drug therapy
- Tomography, X-Ray Computed
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.